Metformin as a Senotherapeutic Agent
Year: 2026
Type: book-chapter
Source: Healthy ageing and longevity
Parent work: Supplements and Drugs for Healthy Longevity
Institutions: Istanbul University-Cerrahpaşa, Istanbul University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: metformin, senotherapy, cellular senescence, aging, age-related diseases, drug repurposing, AMPK signaling, mTOR signaling, autophagy, mitochondrial dysfunction, reactive oxygen species, advanced glycation end products, ATM kinase, DNA repair, genomic instability, epigenetic regulation, DNA methyltransferases, histone modifiers, microRNA, senescence-associated secretory phenotype, NF-κB, Nrf2, chronic inflammation, healthy aging, healthspan
Open Access status: closed
OpenAlex ID: W7130429381
